Cart

0

Business

“Swiss pharma giant Roche agrees $7.1 billion deal to buy Telavant Holdings”

“Swiss health care company Roche on Monday announced it would acquire Telavant Holdings in a $7.1 billion transaction. Telavant produces drugs for people suffering from inflammatory and fibrotic diseases and is in the process of developing a “promising new therapy”… Continue Reading…

Stocks

“Healthcare Sector: Is Aevi Genomic Medicine Inc (GNMX) A Winner?”

“What’s Happening With Aevi Genomic Medicine Inc Stock Today? Aevi Genomic Medicine Inc (GNMX) stock has gained 6.49% while the S&P 500 has fallen -0.61% as of 2:36 PM on Friday, Jan 3. GNMX is higher by $0.01 from the… Continue Reading…

Stocks

Penny Stock Watch: Aevi Genomic Medicine (GNMX) On The Move

The stock market as a whole is up today. It’s hard to pick a bad one it seems. I highly suggest day trading today. My choice is Aevi Genomic Medicine (GNMX). The stock market awaits! Now Go make some money!

Stocks

“Aevi Genomic Medicine (GNMX) Ready to Rid-Off from Unappreciated Views”

“… In Thursday trading session, shares of firm fell of -2.14% along the it has twenty-days moving average price of -17.51% from last close price of $0.14 and perform as resistance to price boundary. GNMX traded 474525 shares versus to… Continue Reading…